Laquinimod fails phase III trial for RRMS patients
Posted: Wed May 24, 2017 4:22 am
In a phase III trial, 2,199 relapsing remitting multiple sclerosis (RRMS) patients were randomised to receive one of two doses of laquinimod or a placebo...Read more - http://www.ms-uk.org/laquinimod-fails-p ... nts-240517